Intelligent Antibody Discovery

Partnering – Targets

 

Target Selection Strategies

Abeome’s ability to develop BioBetter and Novel/Intractable mAb drug candidates offers an extremely valuable opportunity for pharmaceutical and biotechnology companies. Target selection strategies provide higher risk and reward earlier in the novel discovery lifecycle.

target